Sign in
Knowstox

Fundamentals snapshot

Bright Minds Biosciences Inc.

DRUG · NCM · Healthcare · Biotechnology

Current price

$55.32

52-week range

$47.23 - $123.75

Market cap

$545.68M

One-glance verdict

Not enough data

Fair value unavailable

Not enough cash-flow history to value this one with our method.

Balance sheet

Healthy

-9.17x Concerning

Net cash $219.94M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. is a company that creates new medicines, mainly for serious brain-related illnesses like epilepsy. Their money comes from developing these potential drugs, which is a risky but potentially very rewarding process if a medicine works and gets approved. This matters because successful new treatments could significantly help many people who currently have limited options.

Price history

How the share price has moved

—
Loading price history…

Is it cheap or expensive?

Fair value — vs current price $55.32

We couldn't calculate a fair value right now.

lower confidence

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Is it drowning in debt?

Healthy

Net cash $219.9M - more cash than debt. Interest coverage -9.2x.

Net debt $-219.94M
Interest coverage -9.17x

Bright Minds Biosciences Inc. is healthier than 0 of 1 peers on balance-sheet leverage.

Healthy
Worse cushion Baseline Better cushion
DRUG BASELINE Bright Minds Biosciences Inc.

Total debt $46.87K Interest coverage -9.17x This is the baseline the peer rows are being compared against.

-9.17x

What you should know

The case for and against DRUG

0 Rewards 1 Risk

Rewards

Risks

  • Return on equity was -13.6% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
-9.58x
P/B
2.49x
P/S
—
EV/EBITDA
—
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
ROE
-13.6%
ROA
-13.5%

Health

Liquidity and balance-sheet strength

Debt / equity
0.00x
Current ratio
121.97x
Quick ratio
121.44x
Total debt
$46.87K
Total cash
$219.99M

Growth

How the business has been compounding

Revenue TTM
$0.00
Revenue 5Y CAGR
—
EPS TTM
-2.05
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$-6.21M
Free CF TTM
$-6.21M
FCF margin
—

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
—
Last ex-div date
—